Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Gabapentin for Neurorecovery in Spinal Cord Injury
NCT05302999Phase 4Completed
- Sponsor
- MetroHealth Medical Center
- Start
- Mar 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gabapentin in spinal cord injury (SCI), sponsored by MetroHealth Medical Center. Started Mar 2022; status: completed.
02
Drugs
gabapentin
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT05302999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05302999.